INTRODUCTION
Aging is a well known risk factor for development of atherosclerotic vascular disease. The United States Administration on Aging reported that in 2009, 12.8% of the population was 65 y or older (40 million people) and the percentage of elderly people is expected to grow to 19.3% of the population in 2030 (72.1 million people) [1] . Therefore, an understanding of the effects of aging on the surgical management of vascular disease is required to improve the quality of life for this growing population of elderly patients.
Vein is the gold standard and most commonly used conduit for vascular reconstructive surgery. Vein grafts offer longer term patency compared with radial artery grafts in coronary artery bypass surgery, and compared with prosthetic grafts in lower limb arterial bypass surgery [2] [3] [4] . Veins demonstrate wall remodeling when transplanted from their normal venous milieu to an arterial environment, a process called vein graft adaptation [5, 6] . Vein graft adaptation, with smooth muscle cell accumulation and extracellular matrix deposition, is typically known as ''neointimal hyperplasia'', and is part of the vein's remodeling response to the high wall stretch force and shear stress found in the arterial circulation [6, 7] . Since excessive neointimal hyperplasia is responsible for approximately 50% of vein graft failures [8] , the regulation of graft wall thickening, so that vein graft adaptation achieves the optimal wall thickness, is a critical mechanism to understand to determine targets that can potentially improve vein graft durability.
Aging is known to influence the process of vessel wall remodeling in response to injury or transplantation, as well as the ultimate clinical outcomes of vein grafts [9] [10] [11] [12] . Recently, we have shown that aging causes increased vein graft wall inward remodeling and that this inward remodeling involves the vascular endothelial growth factor (VEGF)-Delta/Notch-ephrin/Eph cascade [5] . This cascade is known to determine arterial and venous fate during embryonic vascular development [13, 14] . In embryonic tissues destined to become arteries, the transcription factor sonic hedgehog induces expression of VEGF, which subsequently stimulates the Delta/Notch signaling pathway. Delta/Notch continues to stimulate the arterial fate pathway in developing cells by causing increased ephrinB2 expression with simultaneous suppression of EphB4 expression, i.e. prevention of venous fate determination [15, 16] . In contrast to arterial development, in embryonic tissues destined to become veins, the transcription factor COUP-TFII down-regulates VEGF signaling, preventing Delta/Notch pathway activation, thereby relieving distal suppression to increase EphB4 expression without stimulation of ephrinB2 expression [13, 17] .
Notch is a membrane receptor with four homologues in mammals and is known to be involved in cell fate assignment and pattern formation during embryonic development in the central nervous system, somitogenesis, the endocrine system, immune cells, and cardiovascular development [18] . Notch is activated by the Delta, Serrate, and Lag-2 families of Notch ligands. After activation, Notch can be cleaved to its intracellular domain (NICD) by ADAM10, TACE, and g-secretase, allowing the NICD to become capable of target gene activation [19] . We have previously shown that vein grafts have increased neointimal hyperplasia in aged rats compared with little amounts that develop in young adult rats [5] . We hypothesized that the increased amounts of neointimal hyperplasia in aged rats is due to a defect in Delta-Notch signaling compared to signaling present in young adults rats. Therefore, we examined the expression of Delta like ligand-4 (Dll-4) and Notch homologue-4 (Notch-4) in vein grafts implanted into young hosts, compared with those implanted in aged hosts. In addition, we examined the contribution of vein graft endothelial cells (EC) to Dll-4/Notch-4 expression to examine whether quiescent Dll-4/Notch-4 expression is consistent with effects of aging on EC.
MATERIALS AND METHODS

Animals
All experiments were approved by the Institutional Animal Care and Use Committee at Yale University School of Medicine.
Six-month-old (young adult) and 24-mo-old (aged) Fischer 344 rats were obtained from the National Institute of Aging (NIA) Rodent Colony (Bethesda, MD). Rats were raised in pathogen-free conditions at the NIA and housed locally at least 1 wk prior to surgery. Rat vein graft surgery was performed as previously described [5] . Briefly, the right external jugular vein was exposed and harvested, and reimplanted into the right common carotid artery as an interposition graft under the general anesthesia. Arterial-graft anastomoses were performed with running 10-0 monofilament nylon suture. Vein grafts were harvested and examined 3 wk postoperatively. After exsanguination under anesthesia, vein grafts were flushed with heparinized saline followed with pressure perfusion fixation with 10% formalin prior to excision and histological analysis. Control allografts (Yo Yo and Ag Ag ) were constructed from different animals for vein harvest and subsequent vein graft implantation.
Endothelial Denudation of Vein Grafts
Air denudation of the EC from the preimplantion vein was performed as previously described [20] . After exposure of the external jugular vein, the proximal and distal ends, as well as the major side branches, were ligated with silk suture. All small branches were ligated completely to avoid air embolism. A pin hole for egress of air flow was made on the jugular vein distal end using a 30G needle, and a 30G butterfly needle for inflow of air was inserted from a major side branch of the vein. Air was injected (15 mL/min) into the vein for 4 min, and injured EC, as well as infused air, was subsequently removed by saline flush via the 30G butterfly needle. The external jugular vein was harvested and implanted into the common carotid artery as above.
Real-time Reverse Transcription PCR
The harvested graft was immediately processed by snap freezing with liquid nitrogen, and transferred to À80 C storage. Individual grafts were analyzed individually without pooling. Total RNA was extracted by TRIzol Reagent (Invitrogen, Carlsbad, CA), and RNA clean up was performed with RNeasy mini-kit with DNase-I (Qiagen GmbH, Hilden, Germany) following the manufacturer's instructions. Total RNA concentration and purity were measured by spectrophotometer with absorbance at 260 nm. RNA quality was confirmed by 260/280 nm absorbance ratio.
First strand cDNA was synthesized by Superscript III reverse transcriptase (Invitrogen). Quantitative PCR was performed with SYBR Green master mix (Bio-Rad Laboratories. Hercules, CA). Primers for genes of interest and an internal standard (GAPDH) were used as previous described (Table 1) [21] [22] [23] [24] . Amplification specificity was confirmed by 2% agarose gel electrophoresis, and primer efficiencies were determined by melting curve analysis. All data were normalized by GAPDH. The mean difference between aged and young transcript numbers was plotted in Fig. 1A .
In Situ Whole Mount Staining
The vein graft, and associated vein, was harvested and fixed with cooled 4% paraformaldehyde, subsequently permeabilized with 0.3% Triton X-100 PBS, and blocked with 3% normal goat serum containing PBS. The arteries were probed with rabbit anti-eNOS antibody, mouse anti-caveolin-1 antibody and/or mouse anti-GP130 antibody (BD Transduction Laboratories, San Jose, CA). Alexa Fluor 488 anti-rabbit IgG and 568 anti-mouse IgG (Invitrogen) were used as secondary antibodies. Stained veins and vein grafts were opened under JOURNAL OF SURGICAL RESEARCH: VOL. 171, NO. 1, NOVEMBER 2011 e150 the dissection microscope, and immediately captured images were viewed and saved with an Axioimager A1 (Carl Zeiss, Thornwood, NY) under identical conditions.
Histologic Analysis
The harvested vein grafts were fixed in 10% formalin. Fixed tissues were embedded in paraffin; sections were taken from the midpoint of the graft. All sections were stained with hematoxylin-eosin (H&E) and Masson tricrome (MT) for graft morphologic analysis. For immunofluorescence staining, all sections were treated with proteinase K solution for antigen retrieval, and incubated with primary antibody to protein of interest: Notch-4 goat polyclonal IgG, Dll-4 goat polyclonal IgG (N-19) (Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal anti-alpha smooth muscle actin (Sigma Aldrich, St. Louis, MO). Alexa Fluor-488 and -568 conjugated secondary antibodies (Invitrogen) were used for fluorescent labeling. All immunofluorescence sections were treated by autofluorescent eliminator reagent (Millipore, Billerica, MA), and were mounted with SlowFade Gold antifade reagent with DAPI (Invitrogen) for cell counting. Images were captured by Axioimager A1 (Carl Zeiss) under identical conditions. Morphologic analysis and cell counts were measured by Image J software (NIH). Intimal thickening was measured in the combined intima and medial layers, as rats only have a single external elastic lamina [5] . Cells with a positive signal were counted per high power field, and this was repeated ten times for each sample.
Western Blotting
Jugular veins from young adult and aged animals were suspended in lysis buffer containing protease inhibitors. After mild sonication, each sample had the protein concentration determined using the Protein Assay Reagent (Bio-Rad Laboratories). For denaturing, samples were boiled with 5% beta-mercaptoethanol contained in Laemmli sample buffer. Samples were applied equally protein amount on poly-acrylamide gels. Proteins were transferred to a nitrocellulose membrane and blocked with either BSA or casein (Bio-Rad Laboratories) and then probed with the first antibodies. Detection was performed with ECL detection reagent (GE Healthcare Life Sciences, Piscataway, NJ) using HRP conjugated antibodies (Vector), or Alexa Fluor 680 (Invitrogen) and IRDye 800 (Rockland, Gilbertsville, PA) conjugated antibodies with the Odyssey Infrared Imaging System (Li-Cor Bioscience, Lincolin, NE).
Statistical Analysis
Statistical analysis was carried out with StatView ver. 5.0 (SAS Institute, Cary, NC). Statistical significance was determined using the analysis of variance (ANOVA). Post-hoc test were analyzed by Fisher's protected least significant difference (PLSD) test. All values are expressed as mean 6 standard error and value of P < 0.05 was considered to be statistically significant.
RESULTS
Abnormal Dll-4 and Notch-4 Gene Expression in Vein Grafts in Aged Rats
Since aging influences the VEGF-Dll/Notch-ephrin/ Eph cascade [5] , we hypothesized that some aspect of this pathway is abnormal during vein graft adaptation in aged animals. The gene expression patterns of important members of this cascade were determined in young and aged autologous rat vein grafts. As shown in Fig. 1A , the transcription level of VEGF and its receptors did not show a significant difference between young adult and aged vein grafts after 3 wk of adaptation, the time at which a mature neointimal layer is present. In contrast, Dll-4 mRNA demonstrated significantly low expression in vein grafts when implanted in aged animals, compared with the expression present in young adult vein grafts ( Fig. 1A, 6th lane). Other Notch ligands, Jagged-1 and -2, did not show significant differences between young and aged vein grafts. Interestingly, Notch-4 showed specifically significantly decreased expression in aged compared with young adult grafts, and compared with the similar expression present within the other Notch family members ( Fig. 1A, 11th lane). Downstream molecules ephrin-B2 and Eph-B4 exhibited consistently lower transcriptional levels in aged versus young adult vein grafts and may reflect differences between embryonic and aged adult regulation. These results suggest that Dll-4 and Notch-4 expression are impaired during vein graft adaptation in aged animals, and subsequently the expression of downstream pathway members such as ephrin-B2 and Eph-B4 is also abnormal.
Since Dll-4-Notch-1/4 interaction is known to be important in signaling during specification of embryonic arterial EC fate [18] , we examined the Dll-4 and Notch-4 distribution in preimplantation veins and vein grafts. As expected, the immunofluorescence pattern of staining of young adult veins confirmed Notch-4 expression in luminal endothelial cells (Fig. 1B) . Similarly, Notch-4 immunofluorescence was detected in the endothelial cells of aged veins, without any density differences between young adult and aged veins prior to implantation (Fig. 1B, left panels) . Notch-4 was also detectable in the endothelium of young adult vein grafts, and, interestingly, was also detectable in cells of the outer adventitia of the vein grafts ( Fig 1B,  right panel, white arrowheads) . However, although Notch-4 was detectable in the vein graft endothelium of aged vein grafts, Notch-4-containing cells were not seen in the outer adventitia (Fig. 1B) . Similarly, Dll-4 protein expression was detectable in the preimplantation veins of both young adult and aged rats (data not shown); Dll-4 was also detectable in both the endothelium and outer adventitia of young adult vein grafts, with less adventitial staining detectable in aged vein grafts (Fig. 2) .
Abnormal Venous Endothelium with Aging
Since our data shows that endothelial cells express Dll4 and Notch-4, in both young adult and aged endothelial cells during vein graft adaptation, we determined whether there were any other differences in morphology or gene expression in the endothelium, of young adult and aged endothelium, during vein graft adaptation. Aged endothelial cells and nuclei were slightly larger than those in young adult veins and vein grafts ( Figs. 3 and 4 ). In addition, in young adult veins and vein grafts, the distribution of eNOS and caveolin-1 was aligned to the direction of flow and preserved after vein graft adaptation (Fig. 3A, upper  rows) . However, there were differences in aged veins and vein grafts; in preimplantation aged veins, the distribution of eNOS had an expression pattern consistent with high amounts of colocalization at the Golgi apparatus ( Fig. 4) and reduced distribution to the cell membrane ( Fig. 3A , left panels) and reduced colocalization with caveolin-1 (Fig. 3A, middle and right columns) . This altered pattern of eNOS expression was not aligned to the direction of flow, as it was in young endothelium, and similarly was not aligned after implantation (Fig. 3A) . Not surprisingly, the total amount of expressed eNOS protein was slightly reduced in aged veins in comparison to young adult veins (Fig. 5) .
To determine whether there were any differences in gene expression associated with aging endothelium during vein graft adaptation, the number of transcripts for PDGF-BB and VEGF-A were examined ( Fig. 3B and C). Different temporal patterns of mRNA transcript expression for both platelet-derived growth factor (PDGF-BB) ( Fig. 3B ) and VEGF-A (Fig. 3C) were found, confirming differences in aged vessels during vein graft adaptation.
Aging Influences Both Graft and Host Factors During Vein Graft Adaptation
Because Dll-4 and Notch-4 are expressed in the outer adventitia of the young adult but not the aged vein grafts, it is unclear whether host factors such as infiltrating cells, or graft factors, i.e. cells intrinsic to the vein graft, may be responsible for reduced Dll-4 and/ or Notch-4 expression in aged vein grafts. In addition, we have previously shown that vein grafts implanted into aged rats develop thicker neointimal hyperplasia compared to the little amount that develops in young adult rats [5] . Therefore, to clarify whether graft or host environmental factors affect neointimal thickness in aged rats, we generated a syngeneic exchange vein graft model between young adult and aged animals. The young adult host/young adult graft (Yo Yo ) and the aged host/aged graft (Ag Ag ), were considered control phenotypes. As expected, the Ag Ag group formed consistently thicker neointimal hyperplasia in the vein graft walls compared with the Yo Yo group (Fig. 6 ). Interestingly, both young adult host/aged graft (Yo Ag ) and aged host/young adult graft (Ag Yo ) showed significantly thicker neointimal formation than Yo Yo and similar to the larger amount present in the Ag Ag group (Fig. 6A  and B ). These results suggest that age-dependent neointimal formation is influenced by both factors present within the vein graft as well as factors that are endogenous to the host environment.
Notch-4 Expression in the Outer Adventitia of Vein Grafts is Influenced by Age
To confirm the interaction between Dll-4/Notch-4 expression and age-dependent neointimal hyperplasia, we performed immunofluorescence staining of syngeneic exchanged vein grafts. Consistent with the gene expression pattern described earlier (Fig. 1A) , both Dll-4 and Notch-4 positive cells were seen in the outer adventitia of control young adult (Yo Yo ) grafts and had a significantly decreased presence in aged (Ag Ag ) grafts (Fig. 7) . Dll-4 and Notch-4 positive cells were found equally distributed in luminal endothelial cells of both young adult and aged rat grafts (data not shown). In both heterogeneous vein grafts, i.e. the switched groups Yo Ag and Ag Yo , the number of Dll-4 positive cells was not significantly decreased compared with the young (Yo Yo ) control group (Fig. 7A: upper panels, B) . In comparison, the number of Notch-4 positive cells was diminished in the outer adventitia of both Yo Ag and Ag Yo , to the same degree as in aged (Ag Ag ) grafts ( Fig. 7A: lower  panels, C) . These results suggest that Notch-4 expression in the outer adventitia plays a role in limiting neointimal hyperplasia formation, but Dll-4 expression does not. In addition, this data also suggests that the appearance of Notch-4 positive cells during vein graft adaptation is influenced by both graft age as well as host age, consistent with our data (Fig. 6 ).
Dll-4/Notch-4 Expression Depends on Vein Graft Endothelial Cells
Since EC are known to have a critical role in the development of vascular structures and patterning, and our data suggests a role for the adventitia in regulating the differential response of young adult and aged vein grafts ( Figs. 6 and 7) , we wanted to test whether vein graft EC play a role in vein graft adaptation. To test our hypothesis, we generated an autologous vein graft model in which the EC were denuded with air, i.e. without a medial layer stretch injury (Fig. 8A) . Evans blue staining of denuded vein grafts confirmed the efficacy of the air denudation (Fig. 8B) . Control aged vein grafts demonstrated increased neointimal hyperplasia compared to control young adult grafts, as expected ( Fig. 8C : right upper panel, between yellow arrowheads). Surprisingly, both the young adult and aged vein grafts that were denuded of EC showed diminished neointimal thickening, with no endothelial cells observed in the mid-portion of the graft (Fig. 8C, 8D) . These results show the critical importance of vein graft EC in regulating vein graft adaptation, e.g. vein graft EC may regulate the normal adaptation response of the vein to the arterial environment.
Vein grafts that were denuded of EC also had both diminished Dll-4 and Notch-4 expression at 3 wk ( Fig. 9) ; there was no detectable endothelial Dll-4 or Notch-4 as there were no detectable EC in the vein grafts, even at 3 wk. In the young adult grafts ( Fig. 9B and D, gray bars), the number of Dll-4 and Notch-4 positive cells was reduced by approximately 50% in denuded vein grafts compared to control vein grafts with intact EC. In comparison, there was very little Dll-4 or Notch-4 expression in aged vein grafts ( Fig. 9B and D, black bars) and this minimal expression was not influenced by EC denudation. These results are consistent with Dll-4 and Notch-4 expression in the outer adventitia being dependent on the presence of an EC monolayer, with reduced Dll-4 and Notch-4 expression in aged vein grafts.
DISCUSSION
Our results suggest that age influences Notch-4 expression in vein grafts, and specifically the loss of Notch-4 is associated with a loss of attenuation of neointima. Notch is known to be instrumental in the processes of vascular structuring and patterning in the embryo [25] as well as in bone marrow-derived cell differentiation to smooth muscle-like cells in vascular lesions [26] . Based on this knowledge, we hypothesized that dysfunction of Notch pathways in aged animals may lead to abnormal vein graft adaptation with thicker neointimal hyperplasia. Since our results show that aged vein grafts have impaired Dll-4/Notch-4 expression ( Fig. 1A) as well as a thicker neointima (Fig. 6B) [5] , our data supports the concept that Notch-4 expression may control the formation and/or regulation of neointimal thickening during vein graft adaptation to the arterial environment. Alternatively, excessive neointimal thickening in aged vein grafts may depend on the presence of a dysfunctional aged endothelium, such that neointima may not form in its absence ( Fig. 8) ; if such is the case, then aged endothelium may have alternative pathways to compensate for dysfunctional delta-Notch signaling. Since Notch signaling is likely to be impaired with aging, and aged vein grafts show exuberant vein graft thickening, we believe that these alternative pathways do play a role in vein graft adaptation.
Differential Effects of Arterial and Venous Endothelium
We believe that one of the most interesting pieces of data that we show is the complete lack of neointimal thickening in response to denudation of the venous endothelium with air (Fig. 8C ). The literature shows many examples of denudation of arterial endothelial cells leading to increased neointimal hyperplasia; however, most of these models use the balloon model of injury, a common experimental model that injures and stretches the media, and not surprisingly leads to increased neointimal thickening. We particularly use the air-denudation method to avoid medial stretch injury. Therefore, our finding that venous intimal hyperplasia does not occur in the absence of venous endothelium suggests that the response to injury in arterial and venous endothelium may be different. This is not surprising since arteries and veins are structurally and developmentally different. In addition, venous intimal hyperplasia depends on Eph-B4 expression [5] , and arteries do not contain Eph-B4, implying different mechanisms of response to injury. However, since our specimens only examine the midpoint of the graft, it is possible that the anastomotic thickening may be regulated by a different mechanism. In addition, our findings may be specific to the Fischer 344 rat model with the air-injury method of EC denudation, described by Clowes et al [27, 28] . Nevertheless, our data is consistent with a critical role for endothelial cell regulation of vein graft adaptation to the arterial environment.
Effects of Host Environment Age
It was surprising that synergenic exchange heterografts between young adult and aged rats presented KONDO ET AL.: AGE-RELATED NOTCH-4 QUIESCENCE e157 similar phenotypes, i.e., a similar amount of neointimal thickening (Fig. 6 ). In contrast, in 2005, Conboy and colleagues described that a young environment rejuvenates aged tissue progenitor cells [29] . Interestingly, this group also showed that a Delta-Notch interaction functions in restoration of regenerative potential in aged tissue [29, 30] . Contrary to their experiments, our results revealed significantly lower Notch-4 expression levels in Ag Yo heterografts compared with young adult controls; furthermore, Notch-4 expression was not rescued in Yo Ag heterografts, although Dll-4 expression was rescued by the young environment (Fig. 7) . These results suggest that Dll-4 expression is dependent on the age of the vein graft, and a young environment is able to rescue impaired expression in aged grafts. In comparison, Notch-4 expression is dependent on both host environment age and vein graft age; advanced host age impairs Notch-4 expression, and advanced graft age impairs the participation of young adult host cells in potentially restoring a young phenotype. This finding may be related to our findings of differential eNOS localization in young adult and aged veins ( Figs. 3 and 4 ), or to the differential expression of growth factors (Fig. 3) . However, the effects of aging on interaction of the Notch and other intracellular signaling pathways is not currently well understood. We believe that the presence of a thick neointima when either the graft or host is aged is consistent with some aspect of Notch signaling being impaired with aging. It is also possible that upstream effects of VEGF or VEGF receptors, such as acquired resistance to VEGF signaling, may be responsible for the diminished Notch signaling in aged vein grafts. Changes in VEGF expression and signaling have been previously shown to be involved with the response to arterial injury [31] , although the differential role of VEGF between young adult and aged animals during vein graft adaptation is not currently known. Our data is consistent with diminished or delayed down-regulation of VEGF-A expression in aged vein grafts (Fig. 3C) , although reduced PDGF-BB expression is also present (Fig. 3B ).
Aging Effects on Vein Graft Adaptation
In addition to their detection in the endothelium, Dll-4 and Notch-4 positive cells are found extensively in the outer adventitia of veins (Figs. 1B, 7, and 9 ). It is well known that the adventitia plays a critical role in the formation of neointimal thickening in vein grafts [6, 32, 33] . Monocytes that have migrated into the adventitia, and possibly progenitor cells resident in the adventitia, are involved in the inflammatory response characteristic of the early stages of vein graft adaptation. Additionally, Dll-4 activates Notch signaling, which is an important factor in inflammation [34] . Since quiescence of Dll-4 and Notch-4 expression in aged grafts is associated with the development of a thicker neointima ( Fig. 7) , we believe that the effects of aging on the adventitia are relevant to vein graft wall remodeling. However, it is not yet clear whether Dll-4 or Notch-4 positive cells are derived from the graft vascular or perivascular cells, or from the host blood and/or bone marrow.
Our results also suggest that Dll-4/Notch-4 expression may be at least partially dependent on the presence of functional EC. Since vein grafts denuded of EC show loss of Dll-4/Notch-4 induction in young adult but not aged rats ( Fig. 9 ), these results suggest that Dll-4/Notch-4 expression is regulated by effects of aging on endothelial cells, i.e., EC senescence. EC are known to play both positive and negative roles during vascular wall remodeling. For instance, EC release of nitric oxide (NO), which prevents platelet activation, chemical mediator secretion, and adhesion molecule expression, all of which may play a role in the limitation of neointimal thickening (Fig. 3) [6, [35] [36] [37] . On the other hand, EC secrete PDGF that leads to accelerated smooth muscle cell proliferation and accumulation during vein graft adaptation ( Fig. 3) [38, 39] . Accordingly, denudation of the vein grafts did not cause neointimal thickening in the aged grafts that have baseline Dll-4/Notch-4 quiescence. These results suggest that Dll-4/Notch-4 expression is a modifier of EC function during vascular remodeling. Finally, we believe that a full elucidation of the role of the Dll-4/Notch-4 pathway is beyond the limits of this rat model and will depend on the better availability of suitable tools for the mouse model.
In conclusion, aging influences vein graft wall remodeling. Both aging of the host environment and aging of the graft itself are associated with relevant effects. Notch-4 expression is down-regulated in an aged background, and is dependent on endothelial cell function. Although aging is extensively studied in many fields, the link of aging to vascular biology is not well understood. Our results suggest that the Notch pathway is an important component of vein graft adaptation and may be a site of age-specific pharmacological modulation.
